Evidence map›Paper›PMID 37680008›Full record

ArticleJournal of veterinary internal medicine

Randomized controlled trial of hydrolyzed fish diets in dogs with chronic enteropathy.

Kenneth W Simpson, Meredith L Miller, John P Loftus, Mark Rishniw, Carol E Frederick, Joseph J Wakshlag

Open access · goldAbstract readRandomized Controlled Trial, Veterinary
In one paragraph

Article in Journal of veterinary internal medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Protein hydrolysates fromTranslational animal science · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kenneth W SimpsonDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID https://orcid.org/0000-0002-9306-8420
Meredith L MillerDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID https://orcid.org/0000-0002-0595-1804
John P LoftusDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID https://orcid.org/0000-0001-7181-7155
Mark RishniwDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID https://orcid.org/0000-0002-0477-1780
Carol E FrederickDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Joseph J WakshlagDepartment of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Cornell University · US

Funding

Farmina Pet Foods 91383: THE EFFECT OF HYDROLIZED FISH PROTEIN DIET
6 · The paper itself

Abstract

backgroundThe role of diet in the pathogenesis and treatment of chronic enteropathies (CE) in dogs is unresolved.

objectivesTo compare the ability of diets composed of hydrolyzed fish, rice starch, and fish oil without (HF) or with prebiotics, turmeric, and high cobalamin (HF+) against a limited ingredient diet containing mixed nonhydrolyzed antigens and oils (control) to resolve clinical signs and maintain serum cobalamin and folate concentrations in dogs with nonprotein losing CE (non-PLE). To determine the ability of hydrolyzed fish diets to support recovery and remission in dogs with PLE. ANIMALS: Thirty-one client-owned dogs with CE: 23 non-PLE, 8 PLE.

methodsRandomized, blinded, controlled trial. Diets were fed for 2 weeks; responders continued for 12 weeks. Nonresponders were crossed over to another diet for 12 weeks. Response was determined by standardized clinical evaluation with long-term follow-up at 26 weeks. Concurrent medications were allowed in PLE.

resultsNineteen of 23 (83%; 95% confidence interval [CI], 60%-94%) non-PLE CE responded clinically to their initial diet, with no difference between diets (P > .05). Four nonresponders responded to another diet, with sustained remission of 18/18 (100%; 95%CI, 78%-100%) at 26 weeks. Serum cobalamin concentration was increased (P < .05) and maintained by diet. Serum folate concentration decreased posttreatment (P < .05) but was restored by dietary supplementation. Hydrolyzed fish diets supported weight gain, serum albumin concentration, and recovery (P < .05) in dogs with PLE. CONCLUSIONS AND CLINICAL IMPORTANCE: Changing diet, independent of antigen restriction or supplemental ingredients, induced long-term remission in dogs with non-PLE CE. Serum cobalamin and folate concentrations were maintained by diet. Hydrolyzed fish diets supported clinical recovery and remission in PLE.

Indexed as

Dog DiseasesFish ProductsInflammatory Bowel DiseasesProtein-Losing EnteropathiesAnimalsDietDogsFolic AcidRetrospective StudiesVitamin B 12Folic AcidVitamin B 12cobalamincurcuminfolateinflammatory bowel diseaselymphangiectasiaprebioticsprotein-losing enteropathy

Identifiers

PMID37680008
PMCPMC10658534
OpenAlexW4386531347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.